Author

Nahid F. Mivechi

Augusta UniversityORCID 0000-0002-3510-9968Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Balveen KauriD· 1 shared Bangxing HongiD· 1 shared David H. MunniD· 1 shared Dong Zhu· 1 shared Dongwen LviD· 1 shared Gregory K. FriedmaniD· 1 shared Haocheng DingiD· 1 shared Konstantina KyritsiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Balveen KaurORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BTK inhibition enhances immunovirotherapy in glioblastoma via tertiary lymphoid structure modulation

Konstantina Kyritsi, Dong Zhu, Haocheng Ding, Gregory K. Friedman, Dongwen Lv, Meng Wang, Nahid F. Mivechi, Ravindra B Kolhe, Theodore S. Johnson, Balveen Kaur, David H. Munn, Bangxing Hong

This study shows that BTK inhibition enhances oncolytic virotherapy in glioblastoma by promoting tertiary lymphoid structure formation and improving immune cell infiltration.

bioRxiv · Jun 4, 2026 · PreprintCancer Biology